Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Septerna valued at $970 million
Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut
Septerna's shares rose about 31% in their market debut on Friday, giving the Goldman Sachs-backed biotech firm a valuation of $970 million.
Septerna Shares Rise 29% on First Trading Day
Septerna stock has risen 29%, to $23.31, since it debuted on the exchange Friday. The San Francisco biotechnology company said Thursday it would sell 16 million shares at $18 apiece, giving the company a projected market capitalization of $288 million.
Chinese robotaxi start-up WeRide files for US$119 million IPO on Nasdaq
The IPO would be one of the largest US listings by a Chinese firm since Didi Global's in 2021 Chinese self-driving start-up WeRide has filed for a US$119.4 million initial public offering (IPO) on Nasdaq and a private placement of US$320.
FierceBiotech
1d
Septerna's $288M IPO is another sign of the market warming to biotech investment
Septerna CEO Jeffrey Finer rang the opening bell on the Nasd | South San Francisco-based Septerna has scored with an upsized ...
1d
Goldman-backed drug developer Septerna raises $288 mln in US IPO
Septerna is seeking a valuation of $743.1 million in its upsized U.S. initial public offering, the Goldman Sachs-backed drug ...
BioPharma Dive
1d
GPCR drugmaker Septerna amasses $288M in IPO
Septerna upped the size of its offering twice before pricing a stock sale that raised funds for its lead candidate, a ...
9h
U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names
Three sizable IPOs priced this past week, joined by a flurry of small issuers and blank check companies - Ingram Micro, ...
FierceBiotech
5d
Septerna plans $158M IPO to fund clinical readouts for GPCR pipeline
Septerna may be yet to disclose “any meaningful clinical data,” but the biotech clearly thinks there will be investor ...
22h
Septerna Shares Jump 42% After IPO Shows Biotech Still Hot
Septerna Inc. shares soared as much as 42% in their trading debut after the biotechnology company raised $288 million in an ...
3d
on MSN
Septerna proposes terms for upsized $175M IPO
Septerna (SEPN), which is developing a treatment for hypoparathyroidism, has proposed terms for an upsized $175M initial ...
1d
Septerna Prices Upsized Initial Public Offering
The gross proceeds from the offering are expected to be $288.0 million, before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on ...
devdiscourse
10h
Health Sector Sees Highs and Lows Amid Rising Costs and Breakthroughs
Recent health news highlights include high costs of weight-loss drugs like Wegovy, Septerna's strong Nasdaq debut, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
biotech
Goldman Sachs
Initial public offering
Feedback